<DOC>
	<DOCNO>NCT01668615</DOCNO>
	<brief_summary>The purpose study determine whether All-trans retinoic acid ( ATRA ) effective treatment refractory idiopathic thrombocytopenic purpura ( RITP ) .</brief_summary>
	<brief_title>Efficacy Immunomudulatory Therapy With All-trans Retinoid Acid Adults With Chronic Immune Thrombocytopenia</brief_title>
	<detailed_description>Idiopathic thrombocytopenic purpura ( ITP ) , acquire immune disease characterize impaired generation autoantibody-specific platelet . At least 30 % adult patient turn refractory ITP . The pathogenesis ITP remain elucidated . Now , CD4+ helper cell classify belong T-helper 1 ( TH1 ) , T-helper 2 ( TH2 ) , T-helper17and Regulory T cell ( Tregs ) . All-trans retinoic acid ( ATRA ) mainly apply skin disease acute promyelocytic leukemia . Recently , ATRA also immunomodulator induce differentiation , proliferation , apoptosis cell , immunomudulatory . In international , investigator first treat RITP ATRA . To investigate therapeutic effect ATRA RITP , use new index cell , cytokine molecular biology three in-depth study mechanism .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<criteria>Clinical diagnosis refratory idiopathic thrombocytopenic purpura Hormone immune suppression , splenectomy invalid Other autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>idiopathicthrombocytopenic purpura</keyword>
	<keyword>all-trans retinoic acid</keyword>
	<keyword>regulory T cell</keyword>
</DOC>